Adlai Nortye

BiotechnologySeries DHangzhou, Chinaadlainortye.com

Latest round

Series D

Last raised

Jul 2021

Total raised

$250M

Investors

15

About Adlai Nortye

, trading as Adlai Nortye, was founded by Yang Lu. The company is a biopharmaceutical company focused on developing drugs for the treatment of cancer and metabolic diseases.25 apiece, in a PIPE transaction. The company specializes in biological medicine research and development, and it offers therapeutic treatments that help patients efficiently fight cancer and metabolic disorders. Adlai Nortye has 23 issued patents and 7 PCT publications. They have considerable experience in peptide and protein medicine and have expanded their knowledge to small compounds and therapeutic antibodies. In the pipeline, the company has multiple preclinical and clinical-stage drug candidates. The company's revenue is generated by selling innovative drugs in the fields of tumor immunology and metabolic diseases, as well as providing related technical services.

Who invested in Adlai Nortye

15 investors across 3 rounds

See all investors in Adlai Nortye

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series D

    Jul 13, 2021

    Amount

    $100M

    Investors

    Locked

  2. Series C

    Aug 4, 2020

    Amount

    $100M

    Investors

    Locked

  3. Series B

    Jun 26, 2018

    Amount

    $50M

    Investors

    Locked

Questions about Adlai Nortye

Who invested in Adlai Nortye?

Adlai Nortye has 15 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Adlai Nortye raised?

Adlai Nortye has raised 3 venture rounds. Sign up free to see how much each round raised and the total.

When did Adlai Nortye last raise money?

Adlai Nortye's most recent round on record is a Series D, in Jul 2021.

What does Adlai Nortye do?

, trading as Adlai Nortye, was founded by Yang Lu.

Where is Adlai Nortye headquartered?

Adlai Nortye is headquartered in Hangzhou, China.

Which VCs invest in companies like Adlai Nortye?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Adlai Nortye's stage. Their profiles are linked below.

Raising like Adlai Nortye? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.